Literature DB >> 7000129

Bronchoalveolar lavage for the preparation of free lung cells: technique and complications.

P Cole, C Turton, H Lanyon, J Collins.   

Abstract

Bronchoalveolar lavage at fibreoptic bronchoscopy enables the peripheral bronchoalveolar free cell population, which consists mainly of lymphocytes and macrophages, to be sampled. The yield is sufficient for detailed morphological and functional investigation of these cells, which can be separated by exploiting the glass-adherent or phagocytic properties of macrophages. Such studies are of particular interest in patients with recurrent chest infections, to detect abnormalities of local cellular immunity; in pulmonary fibrosis to assess activity of the disease and effect of treatment by observing morphology and testing function of free lung cells; and in bronchial carcinoma to investigate local immune responses to the tumour. The procedure is held to be ethical in these circumstances. The lavage consists of irrigation of a segmental bronchus through the fibreoptic bronchoscope with up to 500 ml pH-corrected normal saline solution. It is contraindicated in those with respiratory or cardiac risk, but is tolerated well by most patients. Complications include acute respiratory distress, vasovagal syncope and fever with pulmonary infiltrates. Lavage is associated with a mean fall of PaO2 of 3.0 kPa (22.7 mmHg) and routine oxygen supplementation is recommended.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000129     DOI: 10.1016/0007-0971(80)90055-8

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  10 in total

1.  Temperature and serum proinflammatory cytokine changes in patients with NSCLC after BAL.

Authors:  G Georgiades; P Myrianthefs; K Venetsanou; A Kythreoti; A Kyroudi; C Kittas; G Baltopoulos
Journal:  Lung       Date:  2003       Impact factor: 2.584

Review 2.  Current status of fibreoptic bronchoscopy.

Authors:  D P Dhillon; J V Collins
Journal:  Postgrad Med J       Date:  1984-03       Impact factor: 2.401

3.  Bronchoalveolar lavage.

Authors:  A P Greening
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-26

Review 4.  Assessment of drug disposition in the lung.

Authors:  A S Rebuck; A C Braude
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

5.  Human pulmonary alveolar macrophages with smokers' inclusions: their relation to the cessation of cigarette smoking.

Authors:  R M Agius; A Rutman; R K Knight; P J Cole
Journal:  Br J Exp Pathol       Date:  1986-06

6.  Mast cell and histamine content of human bronchoalveolar lavage fluid.

Authors:  R M Agius; R C Godfrey; S T Holgate
Journal:  Thorax       Date:  1985-10       Impact factor: 9.139

7.  Proportional analysis of respiratory cells obtained by bronchoalveolar lavage.

Authors:  A C Braude; D W Chamberlain; A S Rebuck
Journal:  Can Med Assoc J       Date:  1982-06-15       Impact factor: 8.262

8.  Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

Authors:  K Ward; C O'Connor; C Odlum; M X Fitzgerald
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

9.  Extracellular ATP is a danger signal activating P2X7 receptor in a LPS mediated inflammation (ARDS/ALI).

Authors:  Sanja Cicko; Thomas Christian Köhler; Cemil Korcan Ayata; Tobias Müller; Nicolas Ehrat; Anja Meyer; Madelon Hossfeld; Andreas Zech; Francesco Di Virgilio; Marco Idzko
Journal:  Oncotarget       Date:  2018-07-17

10.  Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumour cells.

Authors:  S Swinburne; M Moore; P Cole
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.